Posts by Erik T. Newman, MD
-
Minimal Clinically Important Differences for Lower Extremity Metastatic Surgery
Orthopaedic oncology researchers at Massachusetts General Hospital worked with Dutch colleagues to conduct the first study to establish minimal clinically important differences on PROMIS questionnaires for patients treated for completed or impending pathological fractures due to lower-extremity metastases.
-
Local Treatment of Extremity Desmoid Tumors Does Not Improve Survival, Function
Surgical resection of desmoid tumors of the extremities, with or without radiation, does not improve long-term function, according to the first study of patient-reported outcomes.
Biography
Dr. Erik T. Newman is a fellowship-trained orthopaedic oncology surgeon who specializes in the care of children and adults with benign and malignant musculoskeletal tumors, metastatic bone disease, and complex pelvic and limb reconstructions.
Dr. Newman received his Bachelor of Arts from Dartmouth College (summa cum laude, Phi Beta Kappa) and his medical degree from Duke University. He completed residency in orthopaedic surgery at the Harvard Combined Orthopaedic Residency Program, where he served as Academic Chief Resident and received the William H. Thomas Award for Excellence in Patient Care and the James H. Herndon Award for Excellence in Teaching and Mentorship. He completed fellowship training in orthopaedic oncology at the Massachusetts General Hospital, Beth Israel Deaconess Medical Center, and Boston Children’s Hospital.
He is a member of the Mass General Sarcoma and Connective Tissue Oncology Center, as well as the Stephan L. Harris Center for Chordoma Care, and is active in teaching medical students, residents, and fellows as an Instructor in Orthopaedic Surgery at Harvard Medical School.
Orthopaedic Care at Mass General
At Mass General, our world-class physicians and surgeons treat the full spectrum of musculoskeletal conditions throughout the body, from sprains and strains on the athletic field to carpal tunnel syndrome. Our team offers innovative, research-based treatments that range from limb-saving oncological procedures to complex spinal reconstruction.